Clinical trial of transcathether arterial chemoembolization combined with non-cytotoxic drugs in hepatocellular carcinoma.
Phase of Trial: Phase IV
Latest Information Update: 18 May 2013
At a glance
- Drugs Celecoxib (Primary) ; Lanreotide (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 18 May 2013 Results presented at the Digestive Disease Week 2013.
- 18 May 2013 Primary endpoint 'Overall-survival-rate' has been met.
- 18 May 2013 Primary endpoint 'Overall-survival-duration' has been met.